Results: The clinical efficacy and bacterial examinations of etimicin sulfate group were distinctively better than the amikacin sulfate treated group with fewer side effects.

• 结果治疗组无论在临床疗效还是细菌学评价上均优于对照组，而不良反应少于对照组，差异显著。